All Clarivate Analytics websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.
Intra-Cellular Therapies Inc., of New York, completed its previously disclosed public offering of 4.75 million shares, and underwriters have exercised an option to buy 661,481 more at the same price.
